In this third of 3 episodes, global HIV experts and advocates discuss the current status of HIV cure research, including key concepts to understand and communicate when counselling patients, colleagues, and the broader community on HIV cure: Latest understanding of the viral reservoirNew insights and questions on the best timing for cure interventionsCurrent investigational strategies showing promiseEthical considerations related to participant education, representation in clinical trials, and planning for broad global accessFaculty: Katharine J. Bar, MDAssociate Professor of MedicineDirector, Penn CFAR Virus and Reservoirs CoreUniversity of PennsylvaniaPhiladelphia, PennsylvaniaJennifer Blanchette, PhDIndependent ContractorClinical Care OptionsColorado, United StatesKrista L. Dong, MDClinical Director, FRESH CohortAssistant Professor of MedicineMassachusetts General HospitalHarvard Medical SchoolBoston, MassachusettsKarine Dubé, DrPH, MPhilAssociate ProfessorUCSD School of MedicineDivision of Infectious Diseases and Global Public HealthSan Diego, CaliforniaRichard JefferysBasic Science, Vaccines & Cure Project DirectorTreatment Action GroupNew York, New YorkSharon R. Lewin, AO, FRACP, PhD, FAA, FAHMSDirectorDoherty InstituteMelbourne Laureate Professor and HeadDepartment of Infectious DiseasesThe University of MelbourneConsultant PhysicianVictorian Infectious Diseases ServiceRoyal Melbourne HospitalConsultant Physician and Adjunct Professor Department of Infectious DiseasesAlfred Hospital and Monash UniversityMelbourne, AustraliaAngelina Namiba Founder Member4M Network of Mentor MothersLondon, United KingdomLink to full program:https://bit.ly/3QFwv7n Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related